Atlas Trials

Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms

Clinical trial NCT02403128 · UNKNOWN

Trial details

NCT number
NCT02403128
Sponsor
Kamal Kishore, MD
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Macular EdemaRetinal Artery Macroaneurysm
Start date
2015-05-14
Primary completion
2020-02-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.